Showing results (21-30 of 142) with videos related to

Sort By:
Pageof 15
Clinical Nephrology|March 27, 2018
Nephritis-associated plasmin receptor (NAPlr) positive glomerulonephritis caused by Aggregatibacter actinomycetemcomitans bacteremia: A case reportYohei Komaru, Kunihiro Ishioka, Takashi Oda, et al.
Cardiorenal Medicine|March 31, 2026
Functional Mitral Regurgitation following Successful Living Donor Kidney Transplant: The VINTAGE StudySumi Hidaka, Mizuki Yamano, Yasuhiro Mochida, et al.
Frontiers in Cardiovascular Medicine|October 21, 2021
Latest Advances in Endothelial Progenitor Cell-Derived Extracellular Vesicles Translation to the ClinicAmankeldi A Salybekov, Aidyn D Kunikeyev, Shuzo Kobayashi, et al.
Journal of Clinical Apheresis|May 10, 2005
LDL-apheresis improves peripheral arterial occlusive disease with an implication for anti-inflammatory effectsShuzo Kobayashi, Hidekazkeu Moriya, Kyouko Maesato, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 6, 2002
Angiotensin II and IGF-I may interact to regulate tubulointerstitial cell kinetics and phenotypic changes in hypertensive ratsShuzo Kobayashi, Hidekazu Moriya, Iwao Nakabayashi, et al.
Journal of Clinical Apheresis|October 22, 2003
LDL-apheresis up-regulates VEGF and IGF-I in patients with ischemic limbShuzo Kobayashi, Hidekazu Moriya, Kousuke Negishi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 24, 2004
Asymptomatic cerebral lacunae in patients with chronic kidney diseaseShuzo Kobayashi, Toshio Ikeda, Hidekazu Moriya, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 14, 2005
Amyloidosis associated with chronic lymphocytic leukemiaRyota Ikee, Shuzo Kobayashi, Noriaki Hemmi, et al.
Biomedicines|March 28, 2024
Artificial Intelligence Reporting Guidelines' Adherence in Nephrology for Improved Research and Clinical OutcomesAmankeldi A Salybekov, Markus Wolfien, Waldemar Hahn, et al.
Cells|December 24, 2021
Personalized Cell Therapy for Patients with Peripheral Arterial Diseases in the Context of Genetic Alterations: Artificial Intelligence-Based Responder and Non-Responder PredictionAmankeldi A Salybekov, Markus Wolfien, Shuzo Kobayashi, et al.
Pageof 15